| Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95%CI) | p value | HR (95%CI) | p value | |
sex | 1.79(1.12–2.89) | 0.02 | 2.71(1.14–6.42) | 0.02 |
Age (years) | 0.84(0.52–1.35) | 0.47 |  |  |
smoking | 1.61(0.99–2.59) | 0.05 | 0.59(0.24–1.44) | 0.25 |
T stage | 0.35(0.20–0.63) | < 0.001 | 1.30(1.06–1.59) | 0.01 |
N stage | 0.95(0.59–1.52) | 0.82 |  |  |
EGFR mutation | 0.94(0.62–1.44) | 0.78 |  |  |
No. mets | 0.92(0.57–1.47) | 0.72 |  |  |
No. mets. Organs | 0.51(0.22–1.18) | 0.12 |  |  |
lung mets | 1.26(0.77–2.06) | 0.37 |  |  |
bone mets | 1.55(0.94–2.55) | 0.08 |  |  |
adrenal gland mets | 2.49(0.90–6.91) | 0.08 |  |  |
brain mets | 1.38(0.85–2.27) | 0.19 |  |  |
LN mets | 1.14(0.70–1.84) | 0.60 |  |  |
Osimertinib | 0.73(0.42–1.27) | 0.27 |  |  |
LCT | 0.48(0.27–0.88) | 0.02 | 0.29(0.12–0.68) | 0.004 |